These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6720538)

  • 1. Antidysrhythmic actions of meobentine sulfate.
    Zimmerman JM; Patterson E; Pitt B; Lucchesi B
    Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
    Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
    Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on bethanidine and meobentine: direct and indirect effects of antifibrillatory drugs.
    Dangman KH; Wang HH; Reynolds RD
    J Cardiovasc Pharmacol; 1986; 8(6):1185-94. PubMed ID: 2434745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diltiazem upon experimental ventricular dysrhythmias.
    Patterson E; Eller BT; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiarrhythmic activity of meobentine sulfate in man.
    Duff HJ; Oates JA; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1984; 6(4):650-6. PubMed ID: 6206320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro.
    Northover BJ
    Br J Pharmacol; 1985 Mar; 84(3):755-63. PubMed ID: 3986433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
    Patterson E; Amalfitano DJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meobentine sulphate (bis[N-4-methoxybenzyl-N'N"-dimethylguanidine]sulphate): a new antidysrhythmic agent.
    Wastila WB; Copp FC; Walton E; Ellis CH; Maxwell RA
    J Pharm Pharmacol; 1981 Sep; 33(9):594-6. PubMed ID: 6117639
    [No Abstract]   [Full Text] [Related]  

  • 9. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
    Black SC; Chi LG; Mu DX; Lucchesi BR
    J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.
    Kopia GA; Eller BT; Patterson E; Shea MJ; Lucchesi BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):49-61. PubMed ID: 4054216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
    Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
    Black SC; Butterfield JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-current stimuli to the spared epicardium of a large infarct induce ventricular tachycardia.
    Kavanagh KM; Kabas JS; Rollins DL; Melnick SB; Smith WM; Ideker RE
    Circulation; 1992 Feb; 85(2):680-98. PubMed ID: 1735161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.
    Patterson E; Lynch JJ; Lucchesi BR
    J Pharmacol Exp Ther; 1984 Aug; 230(2):519-26. PubMed ID: 6086892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death.
    Chi LG; Mu DX; Driscoll EM; Lucchesi BR
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):312-24. PubMed ID: 1697389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
    J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia.
    Benditt DG; Benson DW; Dunnigan A; Kriett JM; Pritzker MR; Bacaner MB
    Am J Cardiol; 1984 May; 53(9):1268-74. PubMed ID: 6711426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrillatory actions of d,l-nadolol in a conscious canine model of sudden coronary death.
    Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(5):737-44. PubMed ID: 6195459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic ventricular tachyarrhythmias in the conscious dog: prevention by UM-272 (dimethylpropranolol).
    Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1981; 3(4):769-80. PubMed ID: 6167806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.